News - Cardio-vascular

Filter

Current filters:

Cardio-vascular

Popular Filters

201 to 225 of 527 results

Bayer's Xarelto gains EU clearance for secondary prevention after ACS

28-05-2013

German chemical and pharma group Bayer (BAYN: DE) says that its novel oral anticoagulant Xarelto (rivaroxaban)…

BayerCardio-vascularEuropeJohnson & JohnsonPharmaceuticalRegulationXarelto

Positive clinical results for Zensun's Neucardin CHF patients

23-05-2013

USA and China-based Zensun Science & Technology has revealed positive results of four completed Phase…

Cardio-vascularNeucardinPharmaceuticalResearchSciClone PharmaZensun

Swedish registry questions superiority of bivalirudin over heparin in patients undergoing PCI for NSTE-ACS

22-05-2013

Results from a large observational study reported at EuroPCR 2013 (the official annual meeting of the…

AngiomaxbivalirudinCardio-vascularheparinPharmaceuticalResearchThe Medicines Company

SciClone gains China rights to Zensun's Neucardin

20-05-2013

USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) today announced that the Company has entered into an…

Asia-PacificCardio-vascularLicensingNeucardinPharmaceuticalSciClone PharmaZensun

New study shows UCB's Neupro reduces NSBP in RLS patient

17-05-2013

Leading Belgian drugmaker UCB (Euronext Brussels: UCB) today (May 17) announced data from a double-blind,…

Cardio-vascularNeuproPharmaceuticalResearchUCB

Trevena and Forest Labs collaborate on TRV027 for acute heart failure

10-05-2013

US GPCR ligand drug developer Trevena and Forest Laboratories (NYSE: FRX) have entered into a collaborative…

Cardio-vascularFinancialForest LaboratoriesLicensingPharmaceuticalTrevenaTRV027

Positive results from sub-analysis of Eliquis ARISTOTLE trial

07-05-2013

US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) reported results from a…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalResearch

Sanofi plans acceleration of expansion into Ukraine this year

07-05-2013

French drug major Sanofi (Euronext: SAN) is considering expanding its presence in Ukraine this year,…

Cardio-vascularDiabetesEuropeMarkets & MarketingPharmaceuticalProductionSanofi

Bristol-Myers gets added indication from US FDA for Sustiva; signs second deal with Ambrx

06-05-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) says that the US Food and Drug Administration has approved…

AmbrxAnti-viralsBiotechnologyBristol-Myers SquibbCardio-vascularDiabetesLicensingNorth AmericaPharmaceuticalRegulationSustiva

US FDA approves Merck & Co's combo cholesterol drug Liptruzet

06-05-2013

The Food and Drug Administration has approved pharma giant Merck & Co's (NYSE: MRK) Liptruzet (ezetimibe…

atorvastatinCardio-vascularezetimibeLiptruzetMerck & CoNorth AmericaPharmaceuticalRegulation

FDA approves CSL's Kcentra and accepts Octapharma Octaplex BLA for reversal of anticoagulation

30-04-2013

The US Food and Drug Administration has approved Kcentra (prothrombin complex concentrate, human) from…

BiotechnologyCardio-vascularCSL BehringCSL LimitedKcentraNorth AmericaOctapharmaOctaplexPharmaceuticalRegulation

Daiichi Sankyo to support Phase I clinical study of anticoagulant activity reverser for edoxaban

25-04-2013

USA-based Perosphere and Japanese drug major Daiichi Sankyo(TYO: 4568) have entered into a clinical trial…

Cardio-vascularDaiichi SankyoedoxabanPER977PharmaceuticalResearch

Merck & Co opens new $120 million manufacturing plant in China

19-04-2013

US Pharma giant Merck & Co (NYSE: MRK) has opened its new pharmaceutical manufacturing facility in Hangzhou,…

Asia-PacificCardio-vascularDiabetesFinancialMerck & CoPharmaceuticalProductionRespiratory and Pulmonary

Draft guidance from NICE recommends Bayer's Xarelto for PE and DVT

19-04-2013

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) this morning (April 19)…

BayerCardio-vascularEuropePharmaceuticalPricingRegulationXarelto

US FDA accepts NDAs for Otsuka's tolvaptan and BTG's Varisolve

12-04-2013

Japanese mid-sized drugmaker Otsuka Pharmaceutical (TYO: 4578) says that the US Food and Drug Administration…

BTGCardio-vascularNephrology and HepatologyNorth AmericaOtsukaPharmaceuticalRare diseasesRegulationtolvaptanVarisolve

Pivotal Therapeutics' Vascazen meets primary endpoint in Reveal trial

09-04-2013

Canadian specialty pharma firm Pivotal Therapeutics (CNSX: PVO), with a focus on Omega-3 therapies for…

Cardio-vascularPharmaceuticalPivotal TherapeuticsResearchVascazen

Arrhythmia drug amiodarone "may increase cancer risk"

08-04-2013

One of the most widely used drugs to treat arrhythmias, amiodarone, may increase the risk of developing…

AmiodaroneCardio-vascularPharmaceuticalResearch

Kowa and Daiichi Sankyo to end joint marketing partnership in Japan

07-04-2013

Privately-held Japanese drugmaker Kowa and pharma major Daiichi Sankyo (TYO: 4568) say they will be ending…

Asia-PacificCardio-vascularDaiichi SankyoKowa PharmaceuticalsLicensingLivaloMarkets & MarketingOlmetecPharmaceutical

Germany's IQWiG finds considerable added benefit for Bristol-Myers/Pfizer's Eliquis

05-04-2013

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalPricingRegulation

Adherence to generic cholesterol-lowering drugs linked to fall in total care costs

04-04-2013

People who regularly take statins to reduce high cholesterol will see lower hospitalization rates according…

Cardio-vascularFinancialGenericsMarkets & MarketingNorth America

201 to 225 of 527 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top